Skip to main content

Table 2 Patient characteristics in the study

From: Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial

 

Bolus group (n = 23)

Infusion group (n = 22)

p value

Age (years)

61 ± 17

60 ± 16

0.732

APACHE II score

22.7 ± 5.6

22.5 ± 7.9

0.950

SAPS II

51.5 ± 11.3

52.2 ± 14.6

0.860

SOFA score

10.0 ± 2.1

10.3 ± 2.4

0.707

PaO2/FiO2 ratio (mm Hg)

193 ± 110

176 ± 75

0.532

Cardiac index (l/minute per m2)

3.8 ± 1.7

3.6 ± 1.5

0.555

Mean arterial pressure (mm Hg)

62 ± 7.5

65 ± 7.9

0.188

Systemic vascular resistance (dyn·s/cm5)

623 ± 221

731 ± 254

0.158

SvO2 (percentage)

61 ± 7.6

64 ± 12

0.462

Hemoglobin (g/l)

106 ± 22

105 ± 19

0.890

Leukocyte count (109/l)

14.1 ± 9.2

9.6 ± 7.7

0.091

Platelet count (109/l)

180 ± 103

141 ± 92

0.191

Plasma C-reactive protein (mg/l)

223 ± 115

197 ± 99

0.428

Serum lactate (mmol/l)

2.3 ± 1.6

2.8 ± 1.9

0.471

Norepinephrine dose (μg/kg per minute)

0.22 ± 0.12

0.19 ± 0.16

0.579

ICU mortality, n (percentage)

4 (17%)

7 (29%)

0.494

  1. APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care unit;
  2. PaO2/FiO2, arterial oxygen pressure/inspiratory fractional oxygen content; SAPS II,
  3. Simplified Acute Physiology Score II; SOFA, Sepsis-related Organ Failure Assessment;
  4. SvO2, mixed venous oxygen saturation.
Back to article page

Critical Care

ISSN: 1364-8535